Rani Therapeutics to Participate in Upcoming September Conferences
Rani Therapeutics plans September 2026 investor conference appearances, including a webcast fireside chat and 1x1 meetings in New York.
Rhea-AI Summary
Rani Therapeutics (RANI) will participate in two investor conferences in September 2026.
The company will attend the 10th Annual Best Ideas Growth (BIG10) Conference hosted by Lake Street Capital Markets on September 10, 2026, in New York, offering 1x1 meetings. It will also join the H.C. Wainwright 28th Annual Global Investment Conference, with a fireside chat on September 14, 2026 at 4:00 p.m. ET presented by CEO Talat Imran and CFO Nicholas Maestas, plus 1x1 meetings, also in New York.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s management team will participate in the upcoming September conferences.
10th Annual Best Ideas Growth (BIG10) Conference hosted by Lake Street Capital Markets
Date: Thursday, September 10, 2026
Format: 1x1 Meetings
Location: New York, NY
H.C. Wainwright 28th Annual Global Investment Conference
Fireside Chat: Monday, September 14, 2026 at 4:00pm E.T.
Presenter: Chief Executive Officer, Talat Imran, and Chief Financial Officer, Nicholas Maestas
Format: Fireside Chat and 1x1 Meetings
Location: New York, NY
Interested parties can access the live webcast for the H.C. Wainwright conference from the Investor Relations section of the company's website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the presentation.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® Capsule™, a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® Capsule technology.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
FAQ
How can investors access the H.C. Wainwright conference fireside chat for Rani Therapeutics?
Interested parties can access the live webcast for the H.C. Wainwright 28th Annual Global Investment Conference from the Investor Relations section of Rani Therapeutics’ website at www.ranitherapeutics.com. A webcast replay will be available after the conclusion of the presentation.
Who will present for Rani Therapeutics at the H.C. Wainwright conference and when?
The fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference is scheduled for Monday, September 14, 2026 at 4:00 p.m. ET, and will be presented by Chief Executive Officer Talat Imran and Chief Financial Officer Nicholas Maestas.